ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification Number) |
Title of Each Class: |
Trading Symbol(s) |
Name of Each Exchange on Which Registered: | ||
☒ |
Accelerated filer |
☐ | ||||
Non-accelerated filer |
☐ |
Smaller reporting company |
||||
Emerging growth company |
Page |
||||
1 |
||||
7 |
||||
28 |
||||
29 |
||||
30 |
||||
32 |
Name |
Year Director First Elected |
Age |
Principal Occupation | |||||||
Irwin Federman |
1999 |
84 |
Chairman of the Board of Directors, Mellanox Technologies, Ltd.; Senior Advisor, U.S. Venture Partners | |||||||
Eyal Waldman |
1999 |
59 |
President and Chief Executive Officer, Mellanox Technologies, Ltd. | |||||||
Glenda Dorchak |
2009 |
65 |
Advisor to and board member of technology companies | |||||||
Amal M. Johnson |
2006 |
67 |
Advisor to and board member of technology companies | |||||||
Jack Lazar |
2018 |
54 |
Advisor to and board member of technology companies | |||||||
Jon A. Olson |
2018 |
66 |
Advisor to and board member of technology companies | |||||||
Umesh Padval |
2018 |
62 |
Partner, Thomvest Ventures | |||||||
David Perlmutter |
2014 |
66 |
Advisor to and board member of technology companies | |||||||
Steve Sanghi |
2018 |
64 |
President, Chief Executive Officer and Chairman of the Board of Directors of Microchip Technology Incorporated | |||||||
Gregory Waters |
2018 |
59 |
Former President, Chief Executive Officer and member of the Board of Directors of Integrated Device Technology, Inc. |
Name |
Age |
Position(s) | ||||
Eyal Waldman |
59 |
President and Chief Executive Officer | ||||
Doug Ahrens |
53 |
Chief Financial Officer | ||||
Michael Kagan |
62 |
Chief Technology Officer | ||||
Marc Sultzbaugh |
56 |
Sr. Vice President of Worldwide Sales | ||||
Amir Prescher |
51 |
Sr. Vice President of End-User Sales & Business Development |
• | Our revenue for 2019 was $1,330.6 million, an increase of 22 percent from revenue in 2018 of $1,088.7 million and a new record high for the Company. |
• | GAAP net income in 2019 was $205.1 million, or $3.62 per diluted share, compared to net income of $134.3 million, or $2.46 per diluted share, in 2018. |
• | Non-GAAP* net income in 2019 was $393.5 million, or $7.13 per diluted share, compared to a net income of $266.5 million, or $5.01 per diluted share, in 2018. |
• | We generated cash from operating activities of $424.8 million for 2019, compared to $264.9 million in 2018. |
* | Please see “Reconciliation of GAAP Net Income to Non-GAAP Net Income” on page 19 of this Form 10-K/A for a reconciliation of GAAP net income to non-GAAP net income. |
Best Practices We Employ |
Practices We Avoid | |||||||
✓ |
Executive stock ownership guidelines of 3x salary for all executive officers and holding requirements to help meet ownership guidelines |
X |
Incentive program designs do not encourage excessive risk taking | |||||
✓ |
Change in control severance requires a double trigger |
X |
Pledging or hedging of shares by officers and directors is not permitted | |||||
✓ |
Compensation committee is comprised entirely of independent directors |
X |
No repricing of underwater options | |||||
✓ |
Compensation committee engages an independent consultant |
X |
No excise tax gross-ups | |||||
✓ |
Compensation Philosophy allows the clawback of excess payments based on false and restated financial statements |
X |
No uncapped short-term incentive award or variable compensation |
Arista Networks, Inc. |
Infinera Corporation | |
Cirrus Logic Inc. |
Marvell Technology Group Ltd | |
Cray Inc. |
Monolithic Power Systems, Inc. | |
Cree, Inc. |
Nice Ltd. | |
CyberArk Software Ltd. |
Pure Storage, Inc. | |
Cypress Semiconductor Corporation |
Semtech Corporation | |
Extreme Networks, Inc. |
Silicon Laboratories Inc | |
Finisar Corporation |
Wix.com Ltd. |
Performance Goal |
Weighting |
Threshold (0% payout) |
Target (100% payout) |
Maximum (200% payout) |
Actual Achievement |
Weighted Achievement Percentage |
||||||||||||||||||
Revenue |
50 |
% | $ | 1.215 billion |
$ | 1.35 billion |
$ | 1.485 billion |
$ | 1.331 billion |
42.8 |
% | ||||||||||||
Non-GAAP operating income (as a percentage of revenue)* |
50 |
% | 28 |
% | 30 |
% | 32 |
% | 28.9 |
% | 22.0 |
% | ||||||||||||
Total |
64.8 |
% |
* | Non-GAAP operating income is adjusted from results based on GAAP excluding share-based compensation expense, amortization expense of acquired intangible assets, acquisition and other charges and restructuring and impairment charges. |
• | an amount equal to the sum of the executive’s annual base salary and target bonus (or if no target bonus was established, then the average of the three most recent annual bonuses paid to the executive), paid in a lump sum to the extent such payment would not incur any penalties under Section 409A of the Code, provided that for Mr. Ahrens, the bonus portion shall be the payment of his first annual bonus up to $150,000 and afterward, the average of the three most recent bonuses paid to him; |
• | in the case of a named executive officer who resides in the United States, if the named executive officer elects COBRA coverage under our group health plan, payment for the cost to continue COBRA coverage for the named executive officer and his eligible dependents for up to 12 months following the termination date; and |
• | for each executive other than Mr. Ahrens, full accelerated vesting of all outstanding and unvested equity awards, and for Mr. Ahrens, accelerated vesting of the following percentage of unvested shares subject to outstanding equity awards: (i) 25% if such termination occurred before July 2, 2019; (ii) 50% if such termination occurs between July 2, 2019 and April 2, 2020; and (iii) 100% if such termination occurs after April 2, 2020. |
• | an amount equal to two times the sum of Mr. Waldman’s annual base salary and target bonus (or if no target bonus was established, then the average of the three most recent bonuses paid to the executive), paid in a lump sum to the extent such payment would not incur any penalties under Section 409A of the Code; and |
• | full accelerated vesting of all outstanding and unvested equity awards. |
• | “ Cause |
• | “ Constructive termination |
• | “ Change in Control |
• | A transaction or series of transactions whereby any person or related group of persons directly or indirectly acquires beneficial ownership of securities of the Company possessing more than 50% of the total combined voting power of the Company’s securities outstanding immediately after such acquisition; or |
• | During any period of two consecutive years, individuals who, at the beginning of such period, constitute the Board together with any new director(s) whose election by the Board or nomination for election by the Company’s shareholders was approved by a vote of at least two thirds of the directors then still in office who either were directors at the beginning of the two- year period or whose election or nomination for election was previously so approved, cease for any reason to constitute a majority thereof; or |
• | The consummation by the Company (whether directly involving the Company or indirectly involving the Company through one or more intermediaries) of (x) a merger, consolidation, reorganization, or business combination or (y) a sale or other disposition of all or substantially all of the Company’s assets in any single transaction or series of related transactions or (z) the acquisition of assets or shares of another entity, in each case other than a transaction: |
(i) | Which results in the Company’s voting securities outstanding immediately before the transaction continuing to directly or indirectly, at least a majority of the combined voting power of the successor entity’s outstanding voting securities immediately after the transaction, and |
(ii) | After which no person or group beneficially owns voting securities representing 50% or more of the combined voting power of the successor entity; provided, however, that no person or group shall be treated as beneficially owning 50% or more of combined voting power of the successor entity solely as a result of the voting power held in the Company prior to the consummation of the transaction; or |
• | The Company’s shareholders approve a liquidation or dissolution of the Company. |
• | Each outstanding option, whether vested or unvested, will be cancelled and converted into the right to receive a cash amount equal to the product of (x) the number of ordinary shares subject to such option, and (y) the excess, if any, of $125.00 over the applicable per share exercise price of the option.full accelerated vesting of all outstanding and unvested equity awards. |
• | Each outstanding option, whether vested or unvested, will be cancelled and converted into the right to receive a cash amount equal to the product of (x) the number of ordinary shares subject to such option, and (y) the excess, if any, of $125.00 over the applicable per share exercise price of the option.full accelerated vesting of all outstanding and unvested equity awards. |
• | Each restricted share unit award granted by the Company that is outstanding immediately prior to the Effective Time and (i) that has previously vested in full but not yet been settled or (ii) is held by a non-employee director (each, a “Cashed-Out Company RSU”) will be cancelled and converted into the right of the holder to receive an amount in cash equal to the product of (x) the number of ordinary shares subject to such restricted share unit award and (y) $125.00. |
• | Each restricted share unit award that is outstanding immediately prior to the Effective Time and is not a Cashed-Out Company RSU will be assumed by NVIDIA and converted automatically into a restricted share unit award covering common shares of NVIDIA having substantially the same terms and conditions as the Company restricted share unit award, including vesting schedule and payment timing, but entitling the holder to a number of NVIDIA common shares equal to the product of the number of ordinary shares that were issuable with respect to the restricted share unit award immediately prior to the Effective Time multiplied by a fraction (the “Exchange Ratio”), the numerator of which is $125.00 and the denominator of which is the volume weighted average price for a common share of NVIDIA on Nasdaq, calculated based on the 10 consecutive trading days ending on the third complete trading day prior to (and excluding) the closing date of the Merger. |
• | At the Effective Time, the level at which the performance goals are satisfied with respect to each outstanding Company performance share unit award will be determined by the compensation committee and approved by the Board in accordance with its terms, which will be the greater of (i) the target number of performance share units and (ii) such number determined based on the Company’s actual achievement of the applicable performance goals as of the closing date of the Merger (such final amount, the “Performance Satisfied PSUs”). The resulting Performance Satisfied PSUs will be assumed by NVIDIA and converted automatically at the Effective Time into a restricted share unit award covering common shares of NVIDIA having substantially the same terms and conditions as the Company performance share unit award, other than the performance goals, but entitling the holder to a number of NVIDIA common shares equal to the product of the number of ordinary shares that were issuable with respect to the Performance Satisfied PSUs multiplied by the Exchange Ratio. |
Year ended December 31, |
||||||||
2019 |
2018 |
|||||||
Reconciliation of GAAP net income to non-GAAP: |
||||||||
GAAP net income |
$ | 205,095 |
$ | 134,258 |
||||
Adjustments: |
||||||||
Share-based compensation expense |
||||||||
Cost of revenues |
3,493 |
1,950 |
||||||
Research and development |
61,315 |
38,922 |
||||||
Sales and marketing |
26,614 |
17,042 |
||||||
General and administrative |
20,696 |
13,428 |
||||||
Total share-based compensation expense |
112,118 |
71,342 |
||||||
Amortization of acquired intangibles: |
||||||||
Cost of revenues |
38,970 |
41,978 |
||||||
Research and development |
778 |
778 |
||||||
Sales and marketing |
6,544 |
8,330 |
||||||
Total amortization of acquired intangibles |
46,292 |
51,086 |
||||||
Settlement costs: |
||||||||
Cost of revenues |
— |
9,161 |
||||||
Total settlement costs |
— |
9,161 |
||||||
Acquisition and other charges: |
||||||||
Cost of revenues |
41 |
— |
||||||
Research and development |
382 |
558 |
||||||
Sales and marketing |
150 |
268 |
||||||
General and administrative |
15,901 |
15,423 |
||||||
Total acquisition and other charges |
16,474 |
16,249 |
Restructuring and impairment charges: |
||||||||
Operating expense |
1,457 |
10,329 |
||||||
Other loss |
1,755 |
1,494 |
||||||
Total restructuring and impairment charges |
3,212 |
11,823 |
||||||
Gain on investments in privately-held companies: |
||||||||
Interest and other, net |
(9,569 |
) | — |
|||||
Non-operating foreign exchange losses: |
||||||||
Interest and other, net |
7,070 |
— |
||||||
Income tax effects and adjustments |
12,802 |
(27,442 |
) | |||||
Non-GAAP net income |
$ | 393,494 |
$ | 266,477 |
||||
Year ended December 31, |
||||||||
2019 |
2018 |
|||||||
GAAP income from operations |
$ | 207,920 |
$ | 112,074 |
||||
GAAP income from operations % |
15.6 |
% | 10.3 |
% | ||||
Share-based compensation expense |
112,118 |
71,342 |
||||||
Settlement costs |
— |
9,161 |
||||||
Amortization of acquired intangibles |
46,292 |
51,086 |
||||||
Acquisition and other charges |
16,474 |
16,249 |
||||||
Restructuring and impairment charges |
1,457 |
10,329 |
||||||
Non-GAAP income from operations |
$ | 384,261 |
$ | 270,241 |
||||
Non-GAAP income from operations % |
28.9 |
% | 24.8 |
% | ||||
Year ended December 31, |
||||||||
2019 |
2018 |
|||||||
GAAP diluted net income per share |
$ | 3.62 |
$ | 2.46 |
||||
Adjustments: |
||||||||
Share-based compensation expense |
1.98 |
1.30 |
||||||
Amortization of acquired intangibles |
0.82 |
0.93 |
||||||
Settlement costs |
— |
0.17 |
||||||
Acquisition and other charges |
0.29 |
0.30 |
||||||
Restructuring and impairment charges |
0.06 |
0.22 |
||||||
Gain on investments in privately-held companies |
(0.17 |
) | — |
|||||
Non-operating foreign exchange losses |
0.11 |
— |
||||||
Income tax effects and adjustments |
0.23 |
(0.50 |
) | |||||
Effect of dilutive securities under GAAP |
0.22 |
0.16 |
||||||
Total options vested and exercisable |
(0.03 |
) | (0.03 |
) | ||||
Non-GAAP diluted net income per share |
$ | 7.13 |
$ | 5.01 |
||||
Umesh Padval, Chair |
Amal M. Johnson |
Jack R. Lazar |
Name and Principal Position |
Year |
Salary ($) |
Bonus ($) (1) |
Stock Awards ($) (2) |
Non-equity Incentive Plan Compensation ($) (3) |
All Other Compensation ($) |
Total ($) (1) |
|||||||||||||||||||||
Eyal Waldman (9) |
2019 |
640,000 |
— |
6,288,635 |
421,241 |
431,037 |
(4) | 7,780913 |
||||||||||||||||||||
President & Chief |
2018 |
608,668 |
— |
6,315,168 |
738,710 |
235,312 |
7,897,858 |
|||||||||||||||||||||
Executive Officer |
2017 |
604,072 |
— |
4,585,500 |
— |
234,988 |
5,424,560 |
|||||||||||||||||||||
Doug Ahrens |
2019 |
428,371 |
150,000 |
3,155,460 |
— |
11,651 |
(5) | 3,745,482 |
||||||||||||||||||||
Chief Financial Officer |
||||||||||||||||||||||||||||
Amir Prescher (9) |
2019 |
292,634 |
220,000 |
1,553,352 |
— |
67,545 |
(6) | 2,133,531 |
||||||||||||||||||||
Senior Vice President of Business Development |
||||||||||||||||||||||||||||
Michael Kagan (9) |
2019 |
285,094 |
200,000 |
1,433,818 |
— |
63,145 |
(7) | 1,982,057 |
||||||||||||||||||||
Chief Technology Officer |
2018 |
267,286 |
140,000 |
1,202,250 |
— |
57,072 |
1,666,608 |
|||||||||||||||||||||
2017 |
264,680 |
50,000 |
866,150 |
— |
58,670 |
1,239,500 |
||||||||||||||||||||||
Marc Sultzbaugh |
2019 |
400,000 |
— |
537,608 |
— |
11,651 |
(8) | 949,259 |
||||||||||||||||||||
Senior Vice President of |
2018 |
385,000 |
150,000 |
1,242,325 |
— |
11,440 |
1,788,765 |
|||||||||||||||||||||
Worldwide Sales |
2017 |
365,000 |
30,000 |
866,150 |
— |
43,055 |
1,304,205 |
(1) | These amounts reflect bonuses earned in each fiscal year and paid in the subsequent fiscal year as approved by the compensation committee and the Board. |
(2) | Amounts shown in this column for 2019 represent the aggregate grant date fair value of restricted share units, as calculated under FASB ASC Topic 718. The valuation methodology used in determining the value of the restricted share units is described in Note 10 to our consolidated financial statements included in the Annual Report on Form 10-K for the fiscal year ended December 31, 2019. |
(3) | Represents the amount earned by our CEO under his 2019 cash incentive award based on the Company’s achievement of pre-established revenue and non-GAAP operating income (as a percentage of revenue) targets, the terms of which were approved by our compensation committee and Board and, subsequently, our shareholders at our extraordinary general meeting in June 2019. |
(4) | Includes $162,240 in tax equalization payments (including $54,000 for 2018, which amounts were approved in 2019, and $108,240 for 2019), $53,679 contributed to a severance fund, which is mandated by Israeli law, $48,312 in housing and housing-related expense reimbursements, $49,063 in the reimbursement of taxes relating to his housing and housing-related expense reimbursements, $56,755 contributed to an employee education fund on behalf of Mr. Waldman, $41,115 contributed to a retirement fund on behalf of Mr. Waldman, which is mandated by Israeli law, $10,671 for automobile related expenses pursuant to the Company’s automobile leasing program, $2,816 for 401(k) plan matching contribution, $1,069 for a recuperation fund, which is required under Israeli law, $4,740 for Company events and related tax reimbursements, and $577 in the value of the cash cards given to all Israeli employees for the holidays. |
(5) | Includes 401(k) plan matching contribution of $11,200 and $451 in the value of the cash card given to all US employees for the holidays. |
(6) | Includes $24,376 contributed to a severance fund, which is mandated by Israeli law, $21,948 contributed to an employee education fund on behalf of Mr. Prescher, $17,119 contributed to a retirement fund on behalf of Mr. Prescher, which is mandated by Israeli law, $1,518 for automobile related expenses pursuant to the Company’s automobile leasing program, $1,069 for a recuperation fund, which is mandated by Israeli law, $1,309 for Company events, and $206 in the value of the cash cards given to all Israeli employees for the holidays. |
(7) | Includes $22,876 contributed to a severance fund, which is mandated by Israeli law, $20,597 contributed to an employee education fund on behalf of Mr. Kagan, $16,011 contributed to a retirement fund on behalf of Mr. Kagan, which is mandated by Israeli law, $1,069 for a recuperation fund, which is mandated by Israeli law, $2,286 for Company events, and $306 in the value of the cash cards given to all Israeli employees for the holidays. |
(8) | Includes 401(k) plan matching contribution of $11,200 and $451 in the value of the cash card given to all US employees for the holidays. |
(9) | Amounts reported for Messrs. Waldman, Prescher and Kagan in 2019, other than bonuses, are converted from New Israeli Shekels to U.S. dollars using the 2019 average exchange rate of 3.56 New Israeli Shekels to 1 U.S. dollar. Amounts reported for Messrs. Waldman and Kagan in 2018, other than bonuses, are converted from New Israeli Shekels to U.S. dollars using the 2018 average exchange rate of 3.64 New Israeli Shekels to 1 U.S. dollar. Amounts reported for Messrs. Waldman and Kagan in 2017, other than bonuses, are converted from New Israeli Shekels to U.S. dollars using the 2017 average exchange rate of 3.57 New Israeli Shekels to 1 U.S. dollar. |
Name |
Grant Date |
Board/ Committee Action Date |
Estimated Future Payouts Under Non-Equity Incentive Awards (1) |
All Other Stock Awards: Number of Shares of Stock or Units(#) |
Grant Date Fair Value of Stock and Option Awards ($) (2) |
|||||||||||||||||||||||
Threshold ($) |
Target ($) |
Maximum ($) |
||||||||||||||||||||||||||
Eyal Waldman |
650,000 |
1,300,000 |
||||||||||||||||||||||||||
6/20/2019 |
3/26/2019 |
55,696 |
(3) | 6,288,635 |
||||||||||||||||||||||||
Doug Ahrens |
2/1/2019 |
12/18/2018 |
33,000 |
(4) | 3,155,460 |
|||||||||||||||||||||||
Amir Prescher |
4/1/2019 |
3/26/2019 |
13,164 |
(5) | 1,553,352 |
|||||||||||||||||||||||
Michael Kagan |
4/1/2019 |
3/6/2019 |
12,151 |
(5) | 1,433,818 |
|||||||||||||||||||||||
Marc Sultzbaugh |
4/1/2019 |
3/26/2019 |
4,556 |
(5) | 537,608 |
(1) | Represents the threshold, target and maximum amounts payable to Mr. Waldman pursuant to his 2019 cash incentive award, which is earned 50% based on 2019 revenue goals and 50% based on 2019 non-GAAP operating income (as a percentage of revenue) goals. The target and maximum amounts of his award were 100% and 200%, respectively, of his annual base salary. The cash incentive award does not provide for any payout unless target goals are attained. |
(2) | Represents the grant date fair value calculated in accordance with the provisions of FASB ASC Topic 718. |
(3) | Represents restricted share units which vest with respect to 1/4th of the original number of ordinary shares subject thereto on August 1, 2020 and thereafter at a rate of 1/16th of the original number of shares on the first day of each quarterly vesting period of November, February, May and August commencing on November 1, 2020, with the last 1/16th of the original number of shares vesting on August 1, 2023, subject to continued employment with the Company. Mr. Waldman’s 2019 equity awards were approved by the Board and the compensation committee in March 2019, and thereafter by the Company’s shareholders on June 20, 2019. The grant date reflects the date of such shareholder approval. |
(4) | Represents restricted share units which vest with respect to 1/4th of the original number of ordinary shares subject thereto on February 1, 2020 and thereafter at a rate of 1/16th of the original number of shares on the first day of each quarterly vesting period of May, August, November and February, commencing on May 1, 2020, with the last 1/16th of the original number of shares vesting on February 1, 2023, subject to continued employment with the Company. |
(5) | Represents restricted share units which vest with respect to 1/4th of the original number of ordinary shares subject thereto on May 1, 2020 and thereafter at a rate of 1/16th of the original number of shares on the first day of each quarterly vesting period of August, November, February and May, commencing on August 1, 2020, with the last 1/16th of the original number of shares vesting on May 1, 2023, subject to continued employment with the Company. |
Stock Awards |
||||||||||||||||||||
Name |
Vesting Commencement Date |
Number of Shares or Units of Stock that Have Not Vested (#) |
Market Value of Shares or Units of Stock that Have Not Vested ($) (1) |
Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights that Have Not Vested (#) (2) |
Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights that Have Not Vested ($) (1) |
|||||||||||||||
Eyal Waldman |
5/1/2016(3) |
12,500 |
1,464,750 |
|||||||||||||||||
5/1/2017(4) |
33,750 |
3,954,825 |
||||||||||||||||||
8/1/2018(5) |
24,749 |
2,900,088 |
63,000 |
(6) | 7,382,340 |
|||||||||||||||
5/1/2019(7) |
55,696 |
6,526,457 |
||||||||||||||||||
Doug Ahrens |
2/1/2019(8) |
33,000 |
3,866,940 |
|||||||||||||||||
Amir Prescher |
5/1/2016(3) |
2,250 |
263,655 |
|||||||||||||||||
5/1/2017(4) |
6,375 |
747,023 |
||||||||||||||||||
8/1/2018(5) |
10,656 |
1,248,670 |
||||||||||||||||||
2/1/2019(8) |
5,000 |
585,900 |
||||||||||||||||||
5/1/2019(7) |
13,164 |
1,542,558 |
||||||||||||||||||
Michael Kagan |
5/1/2016(3) |
2,000 |
234,360 |
|||||||||||||||||
5/1/2017(4) |
6,375 |
747,023 |
||||||||||||||||||
8/1/2018(5) |
10,312 |
1,208,360 |
||||||||||||||||||
5/1/2019(7) |
12,151 |
1,423,854 |
||||||||||||||||||
Marc Sultzbaugh |
5/1/2016(3) |
2,500 |
292,950 |
|||||||||||||||||
5/1/2017(4) |
6,375 |
747,023 |
||||||||||||||||||
8/1/2018(5) |
10,656 |
1,248,670 |
||||||||||||||||||
5/1/2019(7) |
4,556 |
533,872 |
(1) | Amounts are calculated by multiplying the number of units shown by $117.18 per share, which was the closing price of our ordinary shares on December 31, 2019. |
(2) | Represents performance share units granted in 2018. Because such performance share units were tracking at above target as of December 31, 2019, the maximum number of units is shown. |
(3) | Restricted share units with a vesting commencement date of May 1, 2016 vest with respect to 1/4th of the original number of ordinary shares subject thereto on May 1, 2017 and thereafter at a rate of 1/16th of the original number of shares on the first day of each quarterly vesting period of May, August, November, and February, commencing on August 1, 2017, with the last 1/16th of the original number of shares vesting on May 1, 2020, subject to continued service on each applicable vesting date. |
(4) | Restricted share units with a vesting commencement date of May 1, 2017 vest with respect to 1/4th of the original number of ordinary shares subject thereto on May 1, 2018 and thereafter at a rate of 1/16th of the original number of shares on the first day of each quarterly vesting period of May, August, November, and February, commencing on August 1, 2018, with the last 1/16th of the original number of shares vesting on May 1, 2021, subject to continued service on each applicable vesting date. |
(5) | Restricted share units with a vesting commencement date of August 1, 2018 vest with respect to 1/4th of the original number of ordinary shares subject thereto on August 1, 2019 and thereafter at a rate of 1/16th of the original number of shares on the first day of each quarterly vesting period of November, February, May and August commencing on November 1, 2019, with the last 1/16th of the original number of shares vesting on August 1, 2022, subject to continued employment with the Company. |
(6) | Performance share units vest with respect to 25% based on total shareholder return relative to that of the companies listed on the Philadelphia Semiconductor Index as of the date of grant and as to 75% based on the Company’s average net operating margin, in each case measured over a three-year performance period beginning on January 1, 2018 and ending on December 31, 2020 (or if earlier, upon the occurrence of a change in control of the Company), subject to continued service. Upon achievement of each performance metric at (i) the threshold level, 50% of the shares subject to such performance metric will vest, (ii) the target level, 100% of the shares subject to such performance metric will vest, or (iii) the maximum level, 175% of the shares subject to such performance metric will vest. No shares subject to a performance metric will vest if the applicable performance metric is achieved at below the threshold level. |
(7) | Restricted share units with a vesting commencement date of May 1, 2019 vest with respect to 1/4th of the original number of ordinary shares subject thereto on May 1, 2020 and thereafter at a rate of 1/16th of the original number of shares on the first day of each quarterly vesting period of August, November, February and May, commencing on August 1, 2020, with the last 1/16th of the original number of shares vesting on May 1, 2023, subject to continued employment with the Company. |
(8) | Restricted share units with a vesting commencement date of February 1, 2019 vest with respect to 1/4th of the original number of ordinary shares subject thereto on February 1, 2020 and thereafter at a rate of 1/16th of the original number of shares on the first day of each quarterly vesting period of May, August, November and February, commencing on May 1, 2020, with the last 1/16th of the original number of shares vesting on February 1, 2023, subject to continued employment with the Company. |
Option Awards |
Share Awards |
|||||||||||||||
Name |
Number of Shares Acquired on Exercise (#) |
Value Realized on Exercise ($) (1) |
Number of Shares Acquired on Vesting (#) |
Value Realized on Vesting ($) (2) |
||||||||||||
Eyal Waldman |
— |
— |
68,751 |
7,591,999 |
||||||||||||
Doug Ahrens |
— |
— |
— |
— |
||||||||||||
Amir Prescher |
— |
— |
15,563 |
1,723,590 |
||||||||||||
Michael Kagan |
— |
— |
14,907 |
1,650,829 |
||||||||||||
Marc Sultzbaugh |
47,056 |
3,768,861 |
16,344 |
1,809,203 |
(1) | Represents the difference between the option exercise price and the sale price of the underlying shares at exercise multiplied by the number of shares covered by the exercised option. |
(2) | Represents the vesting date closing market price of our ordinary shares multiplied by the number of restricted share units that vested. |
Name |
Salary Severance ($) |
Bonus Severance ($) |
COBRA Coverage ($) |
Israeli Severance and Benefits ($) (1) |
Value of Accelerated Equity Awards ($) (2) |
Total ($) |
||||||||||||||||||
Eyal Waldman |
1,300,000 |
1,300,000 |
— |
1,058,980 |
22,228,460 |
(3) |
25,887,440 |
|||||||||||||||||
Doug Ahrens |
430,000 |
150,000 |
30,411 |
— |
1,933,470 |
2,543,881 |
||||||||||||||||||
Amir Prescher |
300,000 |
93,333 |
— |
226,609 |
4,387,805 |
5,007,747 |
||||||||||||||||||
Michael Kagan |
290,000 |
96,667 |
— |
577,271 |
3,613,597 |
4,577,535 |
||||||||||||||||||
Marc Sultzbaugh |
400,000 |
93,333 |
29,762 |
— |
2,822,515 |
3,345,610 |
(1) | Includes severance pay and benefits in accordance with Israeli law. The executives are also entitled to such payments and benefits upon retirement, death or termination without cause (as defined in the Israeli Severance Pay Law) not in connection with a change in control. |
(2) | The value of accelerated equity awards is calculated based on the closing price of our common stock on December 31, 2019, which was $117.18 per share. |
(3) | Upon a change in control, the performance share units granted to Mr. Waldman in 2018 will vest based on the greater of target or actual achievement. The value of such performance share units reflected in the table is based on maximum achievement because such performance share units were tracking at approximately the maximum as of December 31, 2019. |
Annual Fees (as of July 25, 2019) |
Annual Fees (January 1, 2017 to July 25, 2019) |
|||||||
Board membership |
$ | 50,000 |
$ | 45,000 |
||||
Additional amounts, as applicable, payable to: |
||||||||
Chairperson of the Board |
$ | 50,000 |
$ | 30,000 |
||||
Chairperson of the audit committee |
$ | 25,000 |
$ | 25,000 |
||||
Chairperson of the compensation committee |
$ | 18,000 |
$ | 15,000 |
||||
Chairperson of the nominating and corporate governance committee |
$ | 10,000 |
$ | 10,000 |
||||
Member of the audit committee (other than chairperson) |
$ | 10,000 |
$ | 10,000 |
||||
Member of the compensation committee (other than chairperson) |
$ | 10,000 |
$ | 7,400 |
||||
Member of the nominating and corporate governance committee (other than chairperson) |
$ | 5,000 |
$ | 5,000 |
Name |
Fees Earned or Paid in Cash ($) |
Share Awards ($) (1) |
All Other Compensation ($) |
Total ($) |
||||||||||||
Glenda Dorchak |
51,024 |
286,344 |
— |
337,368 |
||||||||||||
Irwin Federman |
79,812 |
286,344 |
— |
366,156 |
||||||||||||
Amal Johnson |
53,924 |
286,344 |
— |
340,267 |
||||||||||||
Jack R. Lazar |
63,924 |
286,344 |
— |
350,267 |
||||||||||||
Jon A. Olson |
64,682 |
286,344 |
— |
351,025 |
||||||||||||
Umesh Padval |
61,614 |
286,344 |
— |
347,958 |
||||||||||||
David Perlmutter |
51,736 |
286,344 |
— |
338,080 |
||||||||||||
Steve Sanghi |
56,024 |
286,344 |
— |
342,368 |
||||||||||||
Gregory L. Waters |
76,024 |
286,344 |
25,000 |
(3) |
387,368 |
|||||||||||
Thomas Weatherford (2) |
29,199 |
— |
— |
29,199 |
(1) | Amounts shown in this column represent the grant date fair value of restricted share units granted during 2019, in accordance with FASB ASC Topic 718. The valuation methodology used in determining the value of the RSUs is described in Note 1 to our consolidated financial statements included in this Annual Report on Form 10-K. |
(2) | Pursuant to the agreement entered into between the Company, Starboard Value LP and certain of its affiliates, Mr. Weatherford resigned from the Board effective March 2, 2019. |
(3) | Represents the one-time cash bonus paid to Mr. Waters in recognition of his services with respect to the Company’s sale process and the Merger. |
Name |
Shares Subject to Outstanding Options as of 12/31/19 (#) |
Shares Subject to Unvested Restricted Share Units as of 12/31/19 (#) |
||||||
Glenda Dorchak |
— |
1,477 |
||||||
Irwin Federman |
— |
1,477 |
||||||
Amal Johnson |
— |
1,477 |
||||||
Jack R. Lazar. |
— |
1,477 |
||||||
Jon A. Olson |
— |
1,477 |
||||||
Umesh Padval |
— |
1,477 |
||||||
David Perlmutter |
— |
1,477 |
||||||
Steve Sanghi |
— |
1,477 |
||||||
Thomas Weatherford |
— |
1,477 |
||||||
Gregory L. Waters |
— |
1,477 |
Plan Category |
Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights(a) |
Weighted Average Exercise Price of Outstanding Options, Warrants and Rights ($) (b) (1) |
Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in Column (a)) (c) |
|||||||||
Equity compensation plans approved by security holders (2) |
3,589,353 |
(3) | 63.46 |
4,879,613 |
(4) | |||||||
Equity compensation plans not approved by security holders |
— |
— |
— |
|||||||||
Total |
3,589,353 |
4,879,613 |
(1) | Reflects weighted average price of options only. |
(2) | Consists of the Fourth Amended and Restated Global Share Incentive Plan (2006), the Global Share Incentive Assumption Plan (2010), the Kotura, Inc. Second Amended and Restated 2003 Stock Plan, the IPtronics, Inc. 2013 Restricted Stock Unit Plan, the EZchip Semiconductor Ltd. 2003 Amended and Restated Equity Incentive Plan, the EZchip Semiconductor Ltd. 2007 U.S. Equity Incentive Plan, the Amended and Restated EZchip Semiconductor Ltd. 2009 Equity Incentive Plan, and the Amended and Restated Employee Share Purchase Plan. |
(3) | Consists of 274,005 options and 3,315,348 restricted share units. |
(4) | Includes 2,625,623 shares available for issuance under the Amended and Restated Employee Share Purchase Plan as of December 31, 2019, of which 2,472,654 shares were issued with respect to the purchase period in effect as of December 31, 2019, which ended on February 29, 2020. |
• | each of the named executive officers named in the summary compensation table on page 21; |
• | each of our directors; and |
• | all of our current executive officers and current directors as a group. |
Beneficial Ownership |
||||||||||||||||||||
Name of Beneficial Owner |
Ordinary Shares |
Options Exercisable within 60 Days |
Restricted share Units Vesting or Settled within 60 Days |
Shares Beneficially Owned |
Percentage of Shares Outstanding (1) |
|||||||||||||||
Named Executive Officers and Directors: |
||||||||||||||||||||
Eyal Waldman (2) |
1,900,974 |
— |
14,126 |
1,915,100 |
3.4 |
% | ||||||||||||||
Doug Ahrens |
5,457 |
— |
2,063 |
7,520 |
* |
|||||||||||||||
Michael Kagan |
168,912 |
— |
6,038 |
174,950 |
* |
|||||||||||||||
Marc Sultzbaugh |
89,908 |
— |
4,419 |
94,327 |
* |
|||||||||||||||
Amir Prescher |
62,470 |
— |
6,759 |
69,229 |
* |
|||||||||||||||
Irwin Federman |
45,121 |
— |
422 |
45,543 |
* |
|||||||||||||||
Glenda Dorchak |
15,671 |
— |
422 |
16,093 |
* |
|||||||||||||||
Amal M. Johnson |
44,088 |
— |
422 |
44,510 |
* |
|||||||||||||||
Jack Lazar |
6,238 |
— |
422 |
6,660 |
* |
|||||||||||||||
Jon A. Olson |
6,738 |
— |
422 |
7,160 |
* |
|||||||||||||||
Umesh Padval |
7,638 |
— |
422 |
8,060 |
* |
|||||||||||||||
David Perlmutter |
19,088 |
45,000 |
422 |
64,510 |
* |
|||||||||||||||
Steve Sanghi |
27,638 |
— |
422 |
28,060 |
* |
|||||||||||||||
Gregory Waters |
6,238 |
— |
422 |
6,660 |
* |
|||||||||||||||
All current executive officers and current directors as a group (14 persons) |
2,406,179 |
45,000 |
37,203 |
2,488,382 |
4.4 |
% |
* | Represents beneficial ownership of less than one percent (1%) of the outstanding ordinary shares. |
(1) | The applicable percentage ownership for 5% shareholders, members of our Board, named executive officers and all current executive officers and current directors as a group is based on 56,235,157 ordinary shares outstanding as of March 31, 2020, together with applicable options and restricted share units for such shareholder. The applicable percentage ownership for the other beneficial owners listed in the table is based on the number of outstanding shares as of the dates indicated in the relevant Schedules 13D and 13G filings described in footnote 2 below. Beneficial ownership is determined in accordance with the rules of the SEC, based on factors including voting and investment power with respect to shares. Ordinary shares subject to the options currently exercisable, or exercisable within 60 days of March 31, 2020, and ordinary shares underlying restricted share units that vest within 60 days of March 31, 2020 are deemed outstanding for computing the percentage ownership of the person holding such options but are not deemed outstanding for computing the percentage ownership of any other person. |
(2) | Includes 1,426,041 ordinary shares held by Waldo Holdings 2, a general partnership formed pursuant to the laws of Israel, of which Mr. Waldman is a general partner. Mr. Waldman has sole voting and dispositive power over all of these shares. |
Fiscal Year Ended December 31, |
||||||||
Service Category |
2019 |
2018 |
||||||
Audit Fees |
$ | 1,121,000 |
$ | 867,000 |
||||
Audit-Related Fees |
86,200 |
21,200 |
||||||
Tax Fees |
189,100 |
80,000 |
||||||
All Other Fees |
3,500 |
17,000 |
||||||
Total |
$ | 1,399,800 |
$ | 985,200 |
||||
(a) |
Documents filed as part of this report. |
(b) |
Exhibits. |
Exhibit No. |
Description of Exhibit | |||||||
2.1 |
(1) |
* |
||||||
3.1 |
(2) |
|||||||
4.1 |
(3) |
|||||||
10.1 |
(4) |
** |
||||||
10.2 |
(5) |
** |
||||||
10.3 |
(6) |
** |
||||||
10.3 |
(7) |
** |
||||||
10.4 |
(8) |
** |
||||||
10.5 |
(9) |
** |
||||||
10.6 |
(10) |
** |
||||||
10.7 |
(11) |
** |
||||||
10.8 |
(12) |
** |
||||||
10.9 |
(13) |
** |
10.10 |
(14) |
** |
||||||
10.11 |
(15) |
** |
||||||
10.12 |
(16) |
** |
||||||
10.13 |
(17) |
** |
||||||
10.14 |
(18) |
** |
||||||
10.15 |
(19) |
** |
||||||
10.16 |
(20) |
** |
||||||
10.17 |
(21) |
** |
||||||
10.18 |
(22) |
** |
||||||
10.19 |
(23) |
** |
||||||
10.20 |
(24) |
** |
||||||
10.21 |
(25) |
** |
||||||
10.22 |
(26) |
** |
||||||
10.23 |
(27) |
** |
||||||
10.24 |
(28) |
|||||||
10.25 |
(29) |
|||||||
10.26 |
(30) |
|||||||
10.27 |
(31) |
** |
||||||
10.28 |
(32) |
** |
||||||
10.29 |
(33) |
|||||||
10.30 |
(34) |
*** |
||||||
10.31 |
(35) |
** |
||||||
21.1 |
(36) |
23.1 |
(37) |
|||||||
24.1 |
(38) |
|||||||
31.1 |
(39) |
|||||||
31.2 |
(40) |
|||||||
31.3 |
† |
|||||||
31.4 |
† |
|||||||
32.1 |
(41) |
|||||||
32.2 |
(42) |
|||||||
101.INS |
(43) |
Inline XBRL Instance Document—the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | ||||||
101.SCH |
(44) |
Inline XBRL Taxonomy Extension Schema Document. | ||||||
101.CAL |
(45) |
Inline XBRL Taxonomy Extension Calculation Linkbase Document. | ||||||
101.LAB |
(46) |
Inline XBRL Taxonomy Extension Label Linkbase Document. | ||||||
101.PRE |
(47) |
Inline XBRL Taxonomy Extension Presentation Linkbase Document. | ||||||
101.DEF |
(48) |
Inline XBRL Taxonomy Extension Definition Linkbase Document. | ||||||
104.1 |
(49) |
Cover Page Interactive Data File to the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 (embedded within the Inline XBRL document and included in Exhibit 101). | ||||||
104.2 |
† |
Cover Page Interactive Data File to Amendment No. 1 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 (embedded within the Inline XBRL document). |
(1) |
Incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K (SEC File No. 001-33299) filed on March 11, 2019. | |
(2) |
Incorporated by reference to Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q (SEC File No. 001-33299) filed on August 3, 2018. | |
(3) |
Incorporated by reference to Exhibit 4.1 to the Company’s Annual Report on Form 10-K (SEC File No. 001-33299) filed on February 20, 2020. | |
(4) |
Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (SEC File No. 001-33299) filed on July 25, 2018. | |
(5) |
Incorporated by reference to Exhibit 3.2 to the Company’s Quarterly Report on Form 10-Q (SEC File No. 001-33299) filed on May 5, 2017. |
(6) |
Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (SEC File No. 001-33299) filed on July 25, 2019. | |
(7) |
Incorporated by reference to Exhibit 4.1 to the Company’s Quarterly Report on Form 10-Q (SEC File No. 001-33299) filed on July 29, 2016. | |
(8) |
Incorporated by reference to Appendix A to the Company’s Definitive Proxy Statement on Schedule 14A (SEC File No. 001-33299) filed on April 19, 2012. | |
(9) |
Incorporated by reference to Exhibit 10.2 to the Company’s Registration Statement on Form S-8 (File No. 333-172093) filed on February 7, 2011. | |
(10) |
Incorporated by reference to Exhibit 10.3 to the Company’s Registration Statement on Form S-8 (File No. 333-172093) filed on February 7, 2011. | |
(11) |
Incorporated by reference to Exhibit 10.4 to the Company’s Registration Statement on Form S-8 (File No. 333-172093) filed on February 7, 2011. | |
(12) |
Incorporated by reference to Exhibit 10.5 to the Company’s Registration Statement on Form S-8 (File No. 333-172093) filed on February 7, 2011. | |
(13) |
Incorporated by reference to Exhibit 4.2 to the Company’s Registration Statement on Form S-8 (File No. 333-190631) filed on August 15, 2013. | |
(14) |
Incorporated by reference to Exhibit 4.2 to the Company’s Registration Statement on Form S-8 (File No. 333-189720) filed on July 1, 2013. | |
(15) |
Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (SEC File No. 001-33299) filed on February 7, 2011. | |
(16) |
Incorporated by reference to Exhibit 4.2 to the Company’s Registration Statement on Form S-8 (SEC File No.333-209808) filed on February 29, 2016. | |
(17) |
Incorporated by reference to Exhibit 4.3 to the Company’s Registration Statement on Form S-8 (SEC File No.333-209808) filed on February 29, 2016. | |
(18) |
Incorporated by reference to Exhibit 4.4 to the Company’s Registration Statement on Form S-8 (SEC File No.333-209808) filed on February 29, 2016. | |
(19) |
Incorporated by reference to Exhibit 4.5 to the Company’s Registration Statement on Form S-8 (SEC File No.333-209808) filed on February 29, 2016. | |
(20) |
Incorporated by reference to Exhibit 4.6 to the Company’s Registration Statement on Form S-8 (SEC File No.333-209808) filed on February 29, 2016. | |
(21) |
Incorporated by reference to Exhibit 10.21 to the Company’s Annual Report on Form 10-K (SEC File No. 001-33299) filed on February 16, 2018. | |
(22) |
Incorporated by reference to Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q (SEC File No. 001-33299) filed on August 3, 2018. | |
(23) |
Incorporated by reference to Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q (SEC File No. 001-33299) filed on August 3, 2018. |
(24) |
Incorporated by reference to Exhibit 10.4 to the Company’s Quarterly Report on Form 10-Q (SEC File No. 001-33299) filed on August 3, 2018. | |
(25) |
Incorporated by reference to Exhibit 10.5 to the Company’s Quarterly Report on Form 10-Q (SEC File No. 001-33299) filed on August 3, 2018. | |
(26) |
Incorporated by reference to Exhibit 10.6 to the Company’s Quarterly Report on Form 10-Q (SEC File No. 001-33299) filed on August 3, 2018. | |
(27) |
Incorporated by reference to Exhibit 10.7 to the Company’s Quarterly Report on Form 10-Q (SEC File No. 001-33299) filed on August 3, 2018. | |
(28) |
Incorporated by reference to Exhibit 10.17 to the Company’s Annual Report on Form 10-K (SEC File No. 001-33299) filed on March 7, 2011. | |
(29) |
Incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q (SEC File No. 001-33299) filed on May 5, 2017. | |
(30) |
Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (SEC File No. 001-33299) filed on June 19, 2018. | |
(31) |
Incorporated by referenced to Exhibit 10.27 to the Company’s Annual Report on Form 10-K (SEC File No. 001-33299) filed on February 21, 2019. | |
(32) |
Incorporated by referenced to Exhibit 10.28 to the Company’s Annual Report on Form 10-K (SEC File No. 001-33299) filed on February 21, 2019. | |
(33) |
Incorporated by referenced to Exhibit 10.1 to the Company’s Current Report on Form 8-K (SEC File No. 001-33299) filed on March 11, 2019. | |
(34) |
Incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q (SEC File No. 001-33299) filed on May 9, 2019. | |
(35) |
Incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q (SEC File No. 001-33299) filed on August 1, 2019. | |
(36) |
Incorporated by reference to Exhibit 21.1 to the Company’s Annual Report on Form 10-K (SEC File No. 001-33299) filed on February 20, 2020. | |
(37) |
Incorporated by reference to Exhibit 23.1 to the Company’s Annual Report on Form 10-K (SEC File No. 001-33299) filed on February 20, 2020. | |
(38) |
Incorporated by reference to Exhibit 24.1 to the Company’s Annual Report on Form 10-K (SEC File No. 001-33299) filed on February 20, 2020. | |
(39) |
Incorporated by reference to Exhibit 31.1 to the Company’s Annual Report on Form 10-K (SEC File No. 001-33299) filed on February 20, 2020. | |
(40) |
Incorporated by reference to Exhibit 31.2 to the Company’s Annual Report on Form 10-K (SEC File No. 001-33299) filed on February 20, 2020. | |
(41) |
Incorporated by reference to Exhibit 32.1 to the Company’s Annual Report on Form 10-K (SEC File No. 001-33299) filed on February 20, 2020. |
(42) |
Incorporated by reference to Exhibit 32.2 to the Company’s Annual Report on Form 10-K (SEC File No. 001-33299) filed on February 20, 2020. | |
(43) |
Incorporated by reference to Exhibit 101.INS to the Company’s Annual Report on Form 10-K (SEC File No. 001-33299) filed on February 20, 2020. | |
(44) |
Incorporated by reference to Exhibit 101.SCH to the Company’s Annual Report on Form 10-K (SEC File No. 001-33299) filed on February 20, 2020. | |
(45) |
Incorporated by reference to Exhibit 101.CAL to the Company’s Annual Report on Form 10-K (SEC File No. 001-33299) filed on February 20, 2020. | |
(46) |
Incorporated by reference to Exhibit 101.LAB to the Company’s Annual Report on Form 10-K (SEC File No. 001-33299) filed on February 20, 2020. | |
(47) |
Incorporated by reference to Exhibit 101.PRE to the Company’s Annual Report on Form 10-K (SEC File No. 001-33299) filed on February 20, 2020. | |
(48) |
Incorporated by reference to Exhibit 101.DEF to the Company’s Annual Report on Form 10-K (SEC File No. 001-33299) filed on February 20, 2020. | |
(49) |
Incorporated by reference to Exhibit 104.1 to the Company’s Annual Report on Form 10-K (SEC File No. 001-33299) filed on February 20, 2020. |
* |
The schedules to the Agreement and Plan of Merger have been omitted from this filing pursuant to Item 601(a)(5) of Regulation S-K. The Company will furnish copies of any such schedules to the SEC upon request. | |
** |
Indicates management contract or compensatory plan, contract or arrangement. | |
*** |
Portions of this exhibit have been omitted because they are both (i) not material and (ii) would be competitively harmful if publicly disclosed. | |
† |
Filed herewith. |
MELLANOX TECHNOLOGIES, LTD. | ||
By: |
/s/ EYAL WALDMAN | |
Eyal Waldman President and Chief Executive Officer (principal executive officer) |